Wikidata entity: Q417222
C₂₂H₃₀O₅ (P274)
Quantities
| P4250 | defined daily dose | 7.5 |
| P4250 | defined daily dose | 20 |
| P2067 | mass | 374.209 |
| P3780 | active ingredient in | ... | Q47521456 (???) | ??? |
| P3780 | active ingredient in | ... | Q47521809 (???) | ??? |
| P3780 | active ingredient in | ... | Q48826272 (???) | ??? |
| P3780 | active ingredient in | ... | Q48828118 (???) | ??? |
| P233 | canonical SMILES | String | CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O | ??? |
| P373 | Commons category | String | Methylprednisolone | ??? |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Methylprednisolone.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O | ??? |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q8277 (multiple sclerosis) | multiple sclerosis |
| P2175 | medical condition treated | ... | Q12078 (cancer) | cancer |
| P2175 | medical condition treated | ... | Q183344 (sinusitis) | sinusitis |
| P2175 | medical condition treated | ... | Q187255 (rheumatoid arthritis) | rheumatoid arthritis |
| P2175 | medical condition treated | ... | Q101991 (inflammation) | inflammation |
| P2175 | medical condition treated | ... | Q366868 (congenital adrenal hyperplasia) | congenital adrenal hyperplasia |
| P2175 | medical condition treated | ... | Q170990 (arthritis) | arthritis |
| P2175 | medical condition treated | ... | Q504790 (nephrotic syndrome) | nephrotic syndrome |
| P2175 | medical condition treated | ... | Q1153419 (interstitial lung disease) | interstitial lung disease |
| P2175 | medical condition treated | ... | Q1194520 (graft-versus-host disease) | graft-versus-host disease |
| P2175 | medical condition treated | ... | Q783903 (contact dermatitis) | contact dermatitis |
| P2175 | medical condition treated | ... | Q972514 (optic neuritis) | optic neuritis |
| P2175 | medical condition treated | ... | Q1621830 (lupus nephritis) | lupus nephritis |
| P2175 | medical condition treated | ... | Q1963588 (hematopoietic system disease) | hematopoietic system disease |
| P2175 | medical condition treated | ... | Q5958765 (hypersensitivity) | hypersensitivity |
| P2175 | medical condition treated | ... | Q18555066 (relapsing-remitting multiple sclerosis) | relapsing-remitting multiple sclerosis |
| P2175 | medical condition treated | ... | Q55781316 (osteoarthritis susceptibility 1) | osteoarthritis susceptibility 1 |
| P2175 | medical condition treated | ... | Q56014460 (acute graft versus host disease) | acute graft versus host disease |
| P2175 | medical condition treated | ... | Q7315912 (respiratory distress) | respiratory distress |
| P2175 | medical condition treated | ... | Q8084905 (autoimmune disease) | autoimmune disease |
| P129 | physically interacts with | ... | Q2663095 (Nuclear receptor subfamily 3 group C member 1) | Nuclear receptor subfamily 3 group C member 1 |
| P3489 | pregnancy category | ... | Q3679189 (Australian pregnancy category A) | Australian pregnancy category A |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q185331 (rocuronium) | rocuronium |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q27098039 (atracurium) | atracurium |
| P769 | significant drug interaction | ... | Q81978749 (cisatracurium) | cisatracurium |
| P9989 | stylized name | String | methylPREDNISolone | ??? |
| P279 | subclass of | ... | Q27122040 (6-methylprednisolone) | 6-methylprednisolone |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q422549 (glucocorticoid) | glucocorticoid |
| P2868 | subject has role | ... | Q575136 (antiemetic) | antiemetic |
| P2868 | subject has role | ... | Q581996 (anti-inflammatory agent) | anti-inflammatory agent |
| P2868 | subject has role | ... | Q50377190 (neuroprotective agent) | neuroprotective agent |
| P2868 | subject has role | ... | Q7447768 (selective glucocorticoid receptor agonist) | selective glucocorticoid receptor agonist |
| P2868 | subject has role | ... | Q16909071 (5-lipoxygenase inhibitor) | 5-lipoxygenase inhibitor |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | methylprednisolone | ??? |
Why not click here or view trends?
log id: 2826255